Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma

ORL; Journal for Oto-rhino-laryngology and Its Related Specialties
P D GoumasG C Nikiforidis

Abstract

This preliminary nonrandomized study was conducted to evaluate the clinical usefulness of TATI and CYFRA 21-1 as tumor markers in head and neck squamous cell carcinoma. Serum levels of these markers were measured from 122 subjects of a tertiary-care university hospital, divided into four groups: (1) normal individuals and patients with (2) inflammatory pathology, (3) benign tumors and (4) squamous cell carcinoma of the head and neck. Serum samples were collected before and after treatment, with a mean follow-up period of 12 months. The cutoff level, sensitivity, specificity and likelihood ratio of a positive and negative test were: 21 microg/l, 66.6%, 93.75%, 10.6 and 0.35 for TATI; 3.3 microg/l, 28.5%, 95%, 5.7 and 0.75 for CYFRA 21-1, respectively. Both markers presented elevated mean values and statistically significant differences in the cancer patient group compared with the other groups. Significant differences were also observed between the stage of disease and tumor differentiation. TATI levels seem to relate positively to the course of disease during the follow-up period. Although CYFRA 21-1 values presented significant differences, the majority of them were under the cutoff level. We conclude that TATI seems to play a...Continue Reading

Citations

Mar 20, 2002·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·O PradierC F Hess
Apr 27, 2002·The American Journal of Nursing·Shirley Jordan SeayMelvin Strauss
Aug 2, 2002·The Laryngoscope·Henry C K KwokHamish A Sillars
Oct 5, 2006·Journal for Nurses in Staff Development : JNSD : Official Journal of the National Nursing Staff Development Organization·Cherie Smith-Miller
Mar 19, 2005·Social Work in Health Care·Christine Callahan
Mar 7, 2006·Critical Reviews in Clinical Laboratory Sciences·Annukka Paju, Ulf-Håkan Stenman
Mar 15, 2016·Critical Reviews in Oncology/hematology·Eliete Neves Silva GuerraGraziela De Luca Canto
Sep 13, 2006·International Journal of Oral and Maxillofacial Surgery·L-P ZhongZ-Y Zhang
Nov 16, 2005·The Annals of Otology, Rhinology, and Laryngology·Philippe CéruseFrançois Disant
Aug 25, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A GadducciA R Genazzani
Sep 5, 2019·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Stefan A RudhartStephan Hoch
Dec 15, 2015·Clinical Chemistry·Kati RäsänenUlf-Håkan Stenman
May 14, 2020·International Journal of Molecular Sciences·Milena Matuszczak, Maciej Salagierski
Apr 15, 2020·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Stefan A RudhartStephan Hoch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Nursing Standard
Karen Dearden, Chris Hewitt
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
Y YoshimuraT Harada
© 2021 Meta ULC. All rights reserved